Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested
Are you a healthy African American between the ages of 18 and 60?
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles insulin and glucose. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Haley at 205-975-5825 or email us at nauticalstudy@uabmc.edu.
2022 in review: Our best photos of the year
Each year, UAB’s official photographers capture thousands of images as they document the incredible variety of events and personalities that make up our community. Here are some of our favorite photos from the past 12 months.
4 honored with Provost’s Awards for Faculty Excellence
Ana Oliveira, Sami Raut, Lisa McCormick and Meena Nabavi demonstrated extraordinary commitment to engaging undergraduate students in service learning, undergraduate research and education-abroad experiences.
Beginning Jan. 25, 2023, the National Institutes of Health will implement a new data management and sharing policy, which will increase the rigor, reproducibility and transparency of research and create open access to data.
Do you have Type 2 Diabetes and overweight
The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 78 week research study to look into how well semaglutide once weekly medicine works in participants with obesity and type 2 diabetes
Qualified participants will receive study drug free of charge and may be compensated for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
Tivanisiran for Dry Eye in Subjects with Sjögren’s Syndrome
You may be eligible to take part in the SYL1001_V Study if:
• You are 18 years or older
• You have a diagnosis of Sjögren’s
• Other entry criteria apply and your eligibility will be determined by
the study staff
If you decide to take part in the study, your participation could last approximately 3.5 months and consist of 5 to 6 visits to the study center. You will be reimbursed for each completed visit.
4 ways to honor service members this Veterans Day
Attend the annual wreath-laying, donate to a blanket and clothing drive, read stories from UAB veterans and leave a message of thanks.
Help complete the 2022 Habitat House, built for Eddie Mae Hopkins in Ensley, just in time for Thanksgiving celebrations. Sign up for a volunteer slot on BlazerPulse.
